EMD Serono, Inc. FDA Inspection Record

FEI 1220970 · Inspections, Form 483s, warning letters and import refusals

EMD Serono, Inc. is an FDA-registered facility (FEI 1220970) located in Boston, MA, US. Registered operations: MANUFACTURE. RegDataLab tracks 5 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Jan 13, 2017: Voluntary Action Indicated (VAI)
Inspections on record
5 (4 VAI, 1 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
2, latest Jun 29, 2020
Import refusals
8

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Jan 13, 2017Voluntary Action Indicated (VAI)IND safety report (21 CFR 312.56(c))
General responsibilities of sponsors (21 CFR 312.50)
Jun 17, 2016Voluntary Action Indicated (VAI)Investigations of discrepancies, failures (21 CFR 211.192)
Aug 21, 2012No Action Indicated (NAI)Failure to investigate serious, unexpected events (21 CFR 314.80(c)(1)(ii))
May 18, 2011Voluntary Action Indicated (VAI)Investigations of discrepancies, failures (21 CFR 211.192)
Contamination, chemical or physical change, deterioration (21 CFR 314.81(b)(1)(ii))
Mar 7, 2011Voluntary Action Indicated (VAI)Incomplete periodic safety report (21 CFR 314.80(c)(2)(ii)(A))

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Jun 29, 2020Class IID-1379-2020Cetrotide (cetrorelix acetate for Injection) 0.25 mg, Sterile - for subcutaneous use only…
Defective Container: Market complaints of missing rubber stoppers from drug vial. Missing rubber stoppers could lead to lack of sterility…
Sep 10, 2015Class IIID-1813-2015ClomiPHENE CITRATE Tablets, USP, 50 mg, 10-count (2 foil sealed plastic trays of 5 tablets…
Chemical Contamination: impurity failure due to chemical contamination of the active ingredient.

FDA record score

3 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

5 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIJan 13, 20176 x 0.251.5
Class II recall D-1379-2020, this FEI as the recalling firmJun 29, 20204 x 0.251
Inspection classified VAIJun 17, 201610 years or older, so it adds no points0
Inspection classified VAIMay 18, 201110 years or older, so it adds no points0
Inspection classified VAIMar 7, 201110 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 17, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 17, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 17, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 17, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 17, 2026Newest record Nov 16, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing EMD Serono, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check EMD Serono, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
EMD Serono, Inc.
Location
Boston, MA (US)
Registration Expires
Dec 31, 2026
Operations
MANUFACTURE
Source
decrs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.